Industry News
Decision Counseling Program makes prostate cancer treatment decisions easier
Oct 24, 2013
When the pros and cons of prostate cancer treatment are spelled out using an online interactive program developed by Thomas Jefferson University researchers, more patients choose active surveillance over therapy, according to research presented Wednesday at the Society for Medical Decision Making annual meeting in Baltimore, Maryland... Read More
Older AML patients not found to benefit from sequential GO and chemotherapy
Oct 24, 2013
Results of the randomized, phase III, EORTC/GIMEMA 06012 intergroup trial (AML-17) reported in the Journal of Clinical Oncology show that sequential combination of gemtuzumab ozogamicin (GO) and standard chemotherapy provides no benefit for older patients with acute myeloid leukemia (AML) and is too toxic for patients 70 years of age or more... Read More
Study points to possible treatment for brain disorders
Oct 24, 2013
Clemson University scientists are working to determine how neurons are generated, which is vital to providing treatment for neurological disorders like Tuberous Sclerosis Complex (TSC)... Read More
Coffee consumption cuts liver cancer risk
Oct 23, 2013
Good news for coffee drinkers: researchers from Italy have shown that coffee consumption reduces the risk of liver cancer by about 40%. And some of the results indicate that if you drink three cups a day, the risks are reduced by more than 50%... Read More
Coffee consumption cuts liver cancer risk
Oct 23, 2013
Good news for coffee drinkers: researchers from Italy have shown that coffee consumption reduces the risk of liver cancer by about 40%. And some of the results indicate that if you drink three cups a day, the risks are reduced by more than 50%... Read More
Melanoma patients may benefit from new biomarker
Oct 23, 2013
Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers... Read More
Heavy air pollution in Canadian areas with excess cancers
Oct 23, 2013
A study led by the University of California-Irvine found higher levels of air pollutants in a rural area near Canada's largest oil, gas and tar sand processing areas than in some of the most polluted cities in the world. Men living in this rural area also show higher rates of cancers known to be linked to the contaminants... Read More
Melanoma patients may benefit from new biomarker
Oct 23, 2013
Researchers have discovered a biomarker that could help predict whether patients with melanoma harboring mutations in the BRAF gene are likely to respond to BRAF-targeted treatment. The discovery could help speed up treatment decisions, say the researchers... Read More
Heavy air pollution in Canadian areas with excess cancers
Oct 23, 2013
A study led by the University of California-Irvine found higher levels of air pollutants in a rural area near Canada's largest oil, gas and tar sand processing areas than in some of the most polluted cities in the world. Men living in this rural area also show higher rates of cancers known to be linked to the contaminants... Read More
BRCA-related breast and ovarian cancers showing early response to Investigational PARP inhibitor
Oct 23, 2013
An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23... Read More
Previous Page Next Page